JERSEY
CITY, N.J., Jan. 30,
2024 /PRNewswire/ -- WallachBeth Capital LLC, a
leading provider of capital markets and institutional execution
services, announced today that 60 Degrees Pharmaceuticals, Inc.
("60P"), (NASDAQ: SXTP; SXTPW) specialists in developing and
marketing medicines for infectious diseases, announced today the
pricing of its public offering of 5,260,901 units (the "Units") at
a price to the public of $0.385 per
Unit and 999,076 pre‑funded units (the "Pre‑Funded Units") at a
price to the public of $0.375 per
Pre‑Funded Unit. The closing of the offering is expected to occur
on or about January 31, 2024, subject
to the satisfaction of customary closing conditions.
The underwriters have been granted an option, exercisable within
45 days after the closing of this offering, to purchase shares of
60P's common stock at a price of $0.385 per share and/or Warrants at a price of
$0.01 per Warrant and/or Pre-Funded
Warrants at a price of $0.375 per
Pre-Funded Warrant, or any combination of additional shares of
common stock, Warrants and/or Pre-Funded Warrants, representing, in
the aggregate, up to 15% of the number of Units sold in this
offering, 15% of the Warrants underlying the Units and Pre-Funded
Units sold in this offering and 15% of the Pre-Funded Warrants
underlying the Pre-Funded Units sold in this offering, in all cases
less the underwriting discount to cover over-allotments, if
any.
WallachBeth Capital is the Sole Bookrunner for the Offering
The offering is being conducted pursuant to 60P's registration
statement on Form S‑1 (File No. 333‑276641) previously filed with
the Securities and Exchange Commission ("SEC") and declared
effective by the SEC on January 24,
2024. A final prospectus relating to the offering will be
filed with the SEC and will be available on the SEC's website at
www.sec.gov. Electronic copies of the final prospectus relating to
this offering, when available, may be obtained from WallachBeth
Capital LLC, via email: cap‑mkts@wallachbeth.com, or by calling +1
(646) 237‑8585, or by standard mail at WallachBeth Capital LLC,
Attn: Capital Markets, 185 Hudson St., Suite 1410, Jersey City, NJ 07311, USA.
About WallachBeth Capital LLC
WallachBeth Capital offers a robust range of capital markets and
investment banking services to the healthcare community. The firm's
experience includes initial public offerings, follow-on issues,
PIPE offerings, and private transactions. The firm's website is
located at www.wallachbeth.com.
This news release does not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or
jurisdiction.
Forward-Looking Statements
This press release may include forward-looking statements,
including statements of future expectations regarding the business
and offering of 60P's units. Forward-looking statements can be
identified by words such as "believes," "expects," "estimates,"
"intends," "may," "plans," "will" and similar expressions, or the
negative of these words. Such forward-looking statements are based
on facts and conditions as they exist at the time such statements
are made and predictions as to future facts and conditions. Readers
of this press release are cautioned not to place undue reliance on
any forward-looking statements. We undertake no obligation to
update any forward-looking statement relating to matters discussed
in this press release, except as may be required by applicable
securities laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announces-pricing-of-60-degrees-pharmaceuticals-2-4-million-public-offering-302048008.html
SOURCE WallachBeth Capital LLC